PhD position: Targeted Radioenhancing Nanoparticles for Neuroblastoma (P2602)

PhD position: Targeted Radioenhancing Nanoparticles for Neuroblastoma (P2602) 100% position for 4 years, earliest starting date: 1 January 2027 This PhD project develops ultrasmall, intravenously deliverable hafnium oxide nanoparticles to improve radiotherapy for high-risk neuroblastoma, a pediatric cancer with poor prognosis and limited treatment options. Neuroblastoma remains a major unmet clinical need because high-risk disease is still …